Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Fuji
Farmers Insurance
Johnson and Johnson
Chinese Patent Office
Queensland Health
Express Scripts
Fish and Richardson
Baxter

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089452

« Back to Dashboard
NDA 089452 describes PHENDIMETRAZINE TARTRATE, which is a drug marketed by Sandoz, Vitarine, Usl Pharma, Graham Dm, Ivax Pharms, Mfg Chemists, Nexgen Pharma Inc, Kv Pharm, Barr, Ferndale Labs, Inwood Labs, Tg United Labs, Kvk Tech, Mikart, Elite Labs Inc, Watson Labs, Ivax Sub Teva Pharms, Numark, Solvay, and Pvt Form, and is included in sixty-four NDAs. It is available from twenty-one suppliers. Additional details are available on the PHENDIMETRAZINE TARTRATE profile page.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for NDA: 089452

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 089452

Suppliers and Packaging for NDA: 089452

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
TABLET;ORAL 089452 ANDA C.O. Truxton, Inc. 0463-7500 0463-7500-01 100 TABLET in 1 BOTTLE, PLASTIC (0463-7500-01)
PHENDIMETRAZINE TARTRATE
phendimetrazine tartrate
TABLET;ORAL 089452 ANDA C.O. Truxton, Inc. 0463-7500 0463-7500-10 1000 TABLET in 1 BOTTLE, PLASTIC (0463-7500-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength35MG
Approval Date:Oct 30, 1991TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Daiichi Sankyo
Colorcon
Harvard Business School
Merck
Johnson and Johnson
Cantor Fitzgerald
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot